Tag: Hatch-Waxman Act

FDA Approval Process for Generic Drugs: Legal Basis and ANDA Guide
Pharmacy

FDA Approval Process for Generic Drugs: Legal Basis and ANDA Guide

Explore the legal basis and approval process for FDA authorization of generics, from the Hatch-Waxman Act and ANDA pathways to bioequivalence and patent laws.

180-Day Exclusivity: How Patent Law Blocks Generic Drug Entry
Pharmacy

180-Day Exclusivity: How Patent Law Blocks Generic Drug Entry

The 180-day exclusivity rule was meant to speed up generic drug access-but often delays it. Learn how patent law, FDA rules, and corporate strategy combine to block affordable medications.

180-Day Exclusivity and Authorized Generics: Legal Considerations in U.S. Drug Markets
Pharmacy

180-Day Exclusivity and Authorized Generics: Legal Considerations in U.S. Drug Markets

The 180-day exclusivity rule was meant to reward generic drug companies for challenging patents - but authorized generics let brand-name makers undercut them. This legal loophole is changing how drugs reach patients and who profits.

First-Mover Advantage: How First Generic Drug Makers Dominate the Market
Pharmacy

First-Mover Advantage: How First Generic Drug Makers Dominate the Market

First-mover advantage in generic drugs gives the initial manufacturer up to 90% market share, locked in by pharmacy stocking rules, prescriber habits, and patient loyalty-even after competitors arrive.

Recent Posts
Categories
Tag Clouds